Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 43.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 38.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 36.4 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 32.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 36.3 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 31 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 37.3 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 46.6 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 0.0 | BCD100427B001 | 40.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 0.5 | BCD100427B003 | 46 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 1.0 | BCD100427B007 | 35.2 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 2.0 | BCD100427B011 | 40.6 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 4.0 | BCD100427B015 | 43 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 8.0 | BCD100427B019 | 43.6 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 12.0 | BCD100427B023 | 63.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 24.0 | BCD100427B027 | 48.5 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 34.3 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 35 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 35.9 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 36.4 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 39.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 34.2 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 46.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 0.5 | BCD100427B004 | 42.5 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 1.0 | BCD100427B008 | 42.2 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 2.0 | BCD100427B012 | 32.2 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 4.0 | BCD100427B016 | 38.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 8.0 | BCD100427B020 | 34.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 12.0 | BCD100427B024 | 38.4 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 24.0 | BCD100427B028 | 45 | pmol/sample |